Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Pantoprazole in Infants with GERD
NCT00868296Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Pfizer. Started Mar 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00868296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868296.